These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 27148944)

  • 1. A novel small molecule ameliorates ocular neovascularisation and synergises with anti-VEGF therapy.
    Sulaiman RS; Merrigan S; Quigley J; Qi X; Lee B; Boulton ME; Kennedy B; Seo SY; Corson TW
    Sci Rep; 2016 May; 6():25509. PubMed ID: 27148944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinal Inhibition of CCR3 Induces Retinal Cell Death in a Murine Model of Choroidal Neovascularization.
    Wang H; Han X; Gambhir D; Becker S; Kunz E; Liu AJ; Hartnett ME
    PLoS One; 2016; 11(6):e0157748. PubMed ID: 27309355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isoliquiritigenin from licorice root suppressed neovascularisation in experimental ocular angiogenesis models.
    Jhanji V; Liu H; Law K; Lee VY; Huang SF; Pang CP; Yam GH
    Br J Ophthalmol; 2011 Sep; 95(9):1309-15. PubMed ID: 21719569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repurposing antimalarial aminoquinolines and related compounds for treatment of retinal neovascularization.
    McAnally D; Siddiquee K; Gomaa A; Szabo A; Vasile S; Maloney PR; Divlianska DB; Peddibhotla S; Morfa CJ; Hershberger P; Falter R; Williamson R; Terry DB; Farjo R; Pinkerton AB; Qi X; Quigley J; Boulton ME; Grant MB; Smith LH
    PLoS One; 2018; 13(9):e0202436. PubMed ID: 30208056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secretogranin III as a novel target for the therapy of choroidal neovascularization.
    LeBlanc ME; Wang W; Ji Y; Tian H; Liu D; Zhang X; Li W
    Exp Eye Res; 2019 Apr; 181():120-126. PubMed ID: 30633921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical Proteomics Reveals Soluble Epoxide Hydrolase as a Therapeutic Target for Ocular Neovascularization.
    Sulaiman RS; Park B; Sheik Pran Babu SP; Si Y; Kharwadkar R; Mitter SK; Lee B; Sun W; Qi X; Boulton ME; Meroueh SO; Fei X; Seo SY; Corson TW
    ACS Chem Biol; 2018 Jan; 13(1):45-52. PubMed ID: 29193961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted Intraceptor Nanoparticle for Neovascular Macular Degeneration: Preclinical Dose Optimization and Toxicology Assessment.
    Zhang X; Bohner A; Bhuvanagiri S; Uehara H; Upadhyay AK; Emerson LL; Bondalapati S; Muddana SK; Fang D; Li M; Sandhu Z; Hussain A; Carroll LS; Tiem M; Archer B; Kompella U; Patil R; Ambati BK
    Mol Ther; 2017 Jul; 25(7):1606-1615. PubMed ID: 28236576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiangiogenic effect of dasatinib in murine models of oxygen-induced retinopathy and laser-induced choroidal neovascularization.
    Seo S; Suh W
    Mol Vis; 2017; 23():823-831. PubMed ID: 29225458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Both Autocrine Signaling and Paracrine Signaling of HB-EGF Enhance Ocular Neovascularization.
    Inoue Y; Shimazawa M; Nakamura S; Takata S; Hashimoto Y; Izawa H; Masuda T; Tsuruma K; Sakaue T; Nakayama H; Higashiyama S; Hara H
    Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):174-185. PubMed ID: 29191924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Semaphorin 3A blocks the formation of pathologic choroidal neovascularization induced by transforming growth factor beta.
    Bai Y; Liang S; Yu W; Zhao M; Huang L; Zhao M; Li X
    Mol Vis; 2014; 20():1258-70. PubMed ID: 25352735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammalian Target of Rapamycin (mTOR) as a Potential Therapeutic Target in Pathological Ocular Angiogenesis.
    Nakahara T; Morita A; Yagasaki R; Mori A; Sakamoto K
    Biol Pharm Bull; 2017; 40(12):2045-2049. PubMed ID: 29199229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic rapamycin inhibits retinal and choroidal neovascularization in mice.
    Dejneka NS; Kuroki AM; Fosnot J; Tang W; Tolentino MJ; Bennett J
    Mol Vis; 2004 Dec; 10():964-72. PubMed ID: 15623986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained intraocular vascular endothelial growth factor neutralisation does not affect retinal and choroidal vasculature in Ins2
    Lechner J; Hombrebueno JR; Pedrini E; Chen M; Xu H
    Diab Vasc Dis Res; 2019 Sep; 16(5):440-449. PubMed ID: 31023085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonist of nucleolin, N6L, inhibits neovascularization in mouse models of retinopathies.
    Darche M; Cossutta M; Caruana L; Houppe C; Gilles ME; Habert D; Guilloneau X; Vignaud L; Paques M; Courty J; Cascone I
    FASEB J; 2020 Apr; 34(4):5851-5862. PubMed ID: 32141122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytochrome P450 Oxidase 2C Inhibition Adds to ω-3 Long-Chain Polyunsaturated Fatty Acids Protection Against Retinal and Choroidal Neovascularization.
    Gong Y; Fu Z; Edin ML; Liu CH; Wang Z; Shao Z; Fredrick TW; Saba NJ; Morss PC; Burnim SB; Meng SS; Lih FB; Lee KS; Moran EP; SanGiovanni JP; Hellström A; Hammock BD; Zeldin DC; Smith LE
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1919-27. PubMed ID: 27417579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel bispecific molecule delivered by recombinant AAV2 suppresses ocular inflammation and choroidal neovascularization.
    Li Y; Zhu P; Verma A; Prasad T; Deng H; Yu D; Li Q
    J Cell Mol Med; 2017 Aug; 21(8):1555-1571. PubMed ID: 28332318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apatinib, an Inhibitor of Vascular Endothelial Growth Factor Receptor 2, Suppresses Pathologic Ocular Neovascularization in Mice.
    Kim KL; Suh W
    Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3592-3599. PubMed ID: 28715845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of VEGF secretion and experimental choroidal neovascularization by picropodophyllin (PPP), an inhibitor of the insulin-like growth factor-1 receptor.
    Economou MA; Wu J; Vasilcanu D; Rosengren L; All-Ericsson C; van der Ploeg I; Menu E; Girnita L; Axelson M; Larsson O; Seregard S; Kvanta A
    Acta Ophthalmol; 2008 Nov; 86 Thesis 4():42-9. PubMed ID: 19032681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. β2-Adrenergic Receptor Antagonism Attenuates CNV Through Inhibition of VEGF and IL-6 Expression.
    Lavine JA; Farnoodian M; Wang S; Darjatmoko SR; Wright LS; Gamm DM; Ip MS; Sorenson CM; Sheibani N
    Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):299-308. PubMed ID: 28114591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of TRAF6 alleviates choroidal neovascularization in vivo.
    Ding D; Zhu M; Liu X; Jiang L; Xu J; Chen L; Liang J; Li L; Zhou T; Wang Y; Shi H; Yuan Y; Song E
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2742-2748. PubMed ID: 30103950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.